Syncor Reports Sharply Higher Profit in Quarter
Syncor International, a Chatsworth provider of specialized pharmaceutical services for doctors and hospitals, reported that its fiscal first-quarter earnings jumped 38%, to $2.2 million from $1.6 million a year earlier.
Sales in the quarter ended Aug. 31 rose 26%, to $59.6 million from $47.3 million.
Gene R. McGrevin, Syncor’s president and chief executive officer, attributed the growth in sales and earnings to two new cardiology products.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
